Biomarkers Are Associated With Frailty After Chemo for Breast Cancer
Elisa Becze, BA, ELS, Editor
Voice
Description
High levels of interleukin-6 and C-reactive protein before chemotherapy for breast cancer may predict a patient’s propensity to develop clinical decline and frailty after treatment, according to study findings that researchers reported in the Journal of Clinical Oncology.